JAMA Names Ten Academic Physicians and Nurses to 2026-2027 Editorial Fellowship Program

CHICAGO – A new cohort of 10 academic physicians and nurses join the JAMA Editorial Fellowship Program, designed to engage early career clinical or health services researchers with the JAMA editorial team to learn about editorial decision-making and enhance skills in scientific communication. 

“What began as a small initiative has grown into a highly successful program that provides early-career clinician investigators with an unparalleled opportunity to learn firsthand about editorial decision-making across the JAMA Network,” said JAMA Deputy Editor Joseph Ross, M.D., M.H.S., who leads the program. “Over the past several years, the fellowship has supported the professional development of numerous fellows while expanding to include participants from a broader range of backgrounds, disciplines, and countries.” 

The incoming class includes fellows from the United States, Europe, and Canada, reflecting the JAMA Network’s commitment to global scientific partnership.  

“The JAMA Editorial Fellowship has become a meaningful way for early-career researchers and clinicians to have an immersive experience at the JAMA Network and learn directly from leaders in medical publishing,” said Kirsten Bibbins-Domingo, Ph.D., M.D., M.A.S., Editor in Chief of JAMA and the JAMA Network. “We are pleased to once again provide fellows with a behind-the-scenes view of the peer review and editorial process, helping cultivate the next generation of clinician leaders in academic medicine.” 

Introducing the 2026-2027 JAMA Editorial Fellows: 

Ayomide Bankole, Ph.D., R.N., is an assistant professor at Duke University School of Nursing. Her research focuses on improving healthcare delivery to support aging in place for older adults and their families, with an emphasis on promoting effective, patient centered home based care and informing practice and health policy. 

Ilies Benotmane, M.D., Ph.D., is an associate professor of nephrology at University of Strasbourg in France and a visiting fellow at NCI, NIH (USA). His research examines BK polyomavirus infection, immunosuppression biomarkers, viral complications in kidney transplant recipients, and molecular and epigenetic mechanisms of cancers associated with BK and Merkel cell polyomaviruses. 

Rolf Ankerlund Blauenfeldt, M.D., Ph.D., is a neurologist and clinical associate professor at Aarhus University Hospital in Denmark. His research focuses on cerebrovascular disease, brain health, and acute care systems. He leads investigator-initiated multicenter clinical trials, integrating clinical and translational research to improve diagnosis, prevention, and treatment of cerebrovascular diseases. 

George Goshua, M.D., S.M., F.A.C.P., is a physician-scientist serving as assistant professor in medical oncology and hematology and primary investigator at the Yale Cancer Center. His expertise is in applied health decision science, health economics, and clinical hematology-oncology. 

Meghna Jani, M.R.C.P., M.Sc., Ph.D., F.H.E.A., is an NIHR Advanced Fellow and rheumatologist and senior lecturer at The University of Manchester in United Kingdom. Her research integrates pharmacoepidemiology, artificial intelligence (AI), and predictive modelling using diverse digital datasets to address important drug safety challenges.  

Alexandre Kalimouttou, M.D., Ph.D., M.S., is an anesthesiologist-intensivist at Grenoble Alpes University Hospital in France. His research focuses on causal inference, reinforcement learning, and artificial intelligence applied to sepsis, hemorrhagic shock, and traumatic brain injury, with interests in AI evaluation and reporting. 

Jovan Milosavljevic, M.D., M.S., is an assistant professor of medicine at Albert Einstein College of Medicine and Montefiore Medical Center. His research applies implementation science and real-world evidence to expand diabetes technology use in primary care and advance health equity. 

Rohan Wijesurendra, M.B. BChir, M.A.,  M.Sc., D.Phil., F.R.C.P., F.E.S.C., is Senior Clinical Research Fellow at Oxford Population Health, University of Oxford, and Honorary Consultant Cardiologist and Electrophysiologist at Oxford University Hospitals NHS Foundation Trust in United Kingdom. His research focuses on atrial fibrillation, cardiovascular trials, cardiometabolic risk, and cardiovascular imaging. 

Adela Wu, M.D., is a clinical assistant professor of neurosurgery at Santa Clara Valley Medical Center and Stanford University. She applies mixed methods to her research on integrating palliative care and communication training in neurosurgery, assessing health-related quality-of-life measures, and identifying and mitigating disparities in palliative care utilization in surgery. 

Remziye Zaim, Ph.D., M.B.A., M.Sc., M.S., is an interdisciplinary researcher at the University of Toronto in Canada. Her work integrates AI governance, health technology assessment, regulatory science, public policy, and bioethics to evaluate responsible and sustainable AI applications in clinical care and public health, considering planetary health implications.